Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra‐articular triamcinolone acetonide
Equine Veterinary Journal · 2026
DOI: 10.1002/evj.70150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Journal, 2026. Verfasst von Allen E Page und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Hyperinsulinism, Horse Diseases, Sodium-Glucose Transporter 2 Inhibitors, Bridged Bicyclo Compounds, Heterocyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Intra‐articular (IA) corticosteroids can cause hyperinsulinemia, which can subsequently increase the risk of laminitis, particularly in horses with insulin dysregulation (ID). Sodium glucose cotransporter 2 inhibitors (SGLT2i), a drug class that is being utilised more commonly in horses with insulin dysregulation, could potentially be used to control post‐IA corticosteroid hyperinsulinemia.
Objectives
To determine whether treatment with the SGLT2i drug ertugliflozin decreases hyperinsulinemia following intra‐articular corticosteroid administration in metabolically normal horses.
Methods
Prospective, controlled, cross‐over study design. Eight mixed‐breed, metabolically normal geldings either received no treatment (CTL) or were treated with ertugliflozin (ERT) for 7 days before and 7 days after a total dose of 18 mg of IA triamcinolone acetonide (TA). Samples for resting glucose and insulin concentrations, as well as dynamic oral sugar testing (OST), were collected. Treatments were crossed over and the study repeated. Two‐way, repeated measures analysis of variance was used to identify timepoint by treatment differences ( p < 0.05).
Results
Insulin was significantly lower 2 days after IA TA with ERT treatment at 60 min post‐OST. Resting glucose concentrations were significantly lower with ERT treatment at 8 h, 12 h, 24 h, and 48 h while resting insulin concentrations were significantly lower with ERT treatment at 12 h, 24 h, 48 h, and 72 h post‐IA injection. Main Limitations Non‐insulin dysregulated horses and compounded ertugliflozin were utilised.
Conclusions
Treatment with ertugliflozin decreases glucose and insulin changes following IA corticosteroid administration in metabolically normal horses. Further investigation of this treatment strategy in insulin dysregulated horses is warranted as it may reduce hyperinsulinemia and, therefore, the risk of laminitis with IA corticosteroid administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA.
- College of Veterinary Medicine, Lincoln Memorial University, Harrogate, Tennessee, USA.
ORCID-Profile: Allen E Page, Jenna L McPeek, Emma N Adam
Zitieren
APA
Page, A. E., McPeek, J. L., McGreevy, E., Carattini, S., & Adam, E. N. (2026). Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra‐articular triamcinolone acetonide. Equine Veterinary Journal. https://doi.org/10.1002/evj.70150
Vancouver
Page AE, McPeek JL, McGreevy E, Carattini S, Adam EN. Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra‐articular triamcinolone acetonide. Equine Veterinary Journal. 2026. doi:10.1002/evj.70150
BibTeX
@article{Page2026,
author = {Page, Allen E and McPeek, Jenna L and McGreevy, Ella and Carattini, Sophia and Adam, Emma N},
title = {Treatment with ertugliflozin mitigates the hyperinsulinemic response to intra‐articular triamcinolone acetonide},
journal = {Equine Veterinary Journal},
year = {2026},
doi = {10.1002/evj.70150}
}
EUVIMED